| (S)-5-BOC-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID |
(S)-5-(叔丁氧羰基)-5-氮杂螺[2.4]庚烷-6-羧酸 |
1129634-44-1 |
| 1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)- |
达卡他韦中间体II |
1007882-23-6 |
| ledipasvir interMediate |
(6S)-6-[5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-羧酸叔丁酯 |
1441670-89-8 |
| 2-isopropyl-4-methylpyridin-3-amine |
2-isopropyl-4-methylpyridin-3-amine |
1698239-93-4 |
| (2S)-2-benzhydryl-1-azabicyclo[2.2.2]octan-3-one |
// |
683206-53-3 |
| N-(5-(4-(hydroxymethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
N-(5-(4-(羟基甲基)苯基)-[1,2,4]噻唑并[1,5-A]吡啶-2-基)环丙烷羧酰胺 |
1142936-49-9 |
| 3-AMINO-6-CHLORO-4-PICOLINE |
3-氨基-6-氯-4-甲基吡啶 ** |
66909-38-4 |
| 3-methyl-4-(1,2,4-triazolo[4,3-c]pyrimidin-7-yloxy)-Benzenamine |
SHBF |
2131230-56-1 |
| 2,4(1H,3H)-Quinazolinedione, 8-chloro-6-fluoro- |
8-氯-6-氟-2,4-喹唑啉二醇 |
2090295-70-6 |
| cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide |
GLPG-0634 中间体 |
1142943-96-1 |
| ORM-15341 |
ORM-15341 |
1297537-33-7 |
| 2-Amino-3-nitro-6-picoline |
2-氨基-3-硝基-6-甲基吡啶 |
21901-29-1 |
| 2-amino-6-bromo-5-methylpyrazine |
2-AMINO-6-BROMO-5-METHYLPYRAZINE |
74290-68-9 |
| Carbamic acid, N-(6-iodo-3-pyridinyl)-, 1,1-dimethylethyl ester |
Carbamic acid, N-(6-iodo-3-pyridinyl)-, 1,1-dimethylethyl ester |
1816293-43-2 |
| Z-TRANS-4-HYDROXY-L-PROLINOL |
CBZ-反式-4-羟基-L-脯氨醇 |
95687-41-5 |
| Z-CIS-HYP-OH |
(2S,4S)-1- (苄氧羰基)-4 -羟基吡咯烷 2-羧酸 |
13504-86-4 |
| URB597 |
URB597 |
546141-08-6 |
| 2,4,6-trip-tolyl-1,3,5-triazine |
2,4,6-三对甲苯基-1,3,5-三嗪 |
6726-45-0 |
| 3,3,3-TRIFLUOROALANINE HYDROCHLORIDE |
三氟丙氨酸 |
96105-72-5 |
| 3-(Trifluoromethyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine |
3-(三氟甲基)-6,7-二氢-5H-吡咯并[3,4-B]吡啶 |
905273-66-7 |
